TEMEL, T. Et Al. 2017. Hepattis B related reverse seroconversion after hematopoietic stem cell transplantation or rituximab chemotherapy. Flora , vol.22, no.3 , 132-136.

TEMEL, T., OĞUZ, N., ÖZGENEL, Ş. M., ÜSKÜDAR TEKE, H., GÜNDÜZ, E., & ÖZAKYOL, A., (2017). Hepattis B related reverse seroconversion after hematopoietic stem cell transplantation or rituximab chemotherapy. Flora , vol.22, no.3, 132-136.

TEMEL, TUNCER Et Al. "Hepattis B related reverse seroconversion after hematopoietic stem cell transplantation or rituximab chemotherapy," Flora , vol.22, no.3, 132-136, 2017

TEMEL, TUNCER Et Al. "Hepattis B related reverse seroconversion after hematopoietic stem cell transplantation or rituximab chemotherapy." Flora , vol.22, no.3, pp.132-136, 2017

TEMEL, T. Et Al. (2017) . "Hepattis B related reverse seroconversion after hematopoietic stem cell transplantation or rituximab chemotherapy." Flora , vol.22, no.3, pp.132-136.

@article{article, author={TUNCER TEMEL Et Al. }, title={Hepattis B related reverse seroconversion after hematopoietic stem cell transplantation or rituximab chemotherapy}, journal={Flora}, year=2017, pages={132-136} }